Mckesson Corp
MCK · NYSE · United States · Health Care · Pharma / Biotech / Life Sci
- Coverage
- FY2017–FY2026
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- March
- Last updated
- May 2026
Headline figures
Mckesson Corp at a glance
In FY2026, Mckesson Corp reported revenue of USD 403,430 mn, EBITDA of USD 6,922 mn, EBITDA margin of 1.7%.
| USD mn | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 359,051 | 403,430 | |||
| EBITDA | 5,207 | 6,922 | |||
| EBITDA margin | 1.5% | 1.7% | |||
| Free cash flow | 5,548 | 5,719 |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas